Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - CASH FROM OPERATIONS
Cash from Operations FOLD - Amicus Therapeutics, Inc.
-69.1 M
LAST VALUE
41.59%
2 YEAR CAGR
25.45%
5 YEAR CAGR
-4.20%
10 YEAR CAGR